Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Houston Liver Institute is a private hepatology-focused healthcare organization in Houston, Texas that provides specialty clinical care for liver diseases and related conditions. The practice emphasizes fatty liver disease, including MASLD/MASH, as well as cirrhosis, viral hepatitis, portal hypertension, liver cancer, hepatic encephalopathy, and transplant-related management. It combines outpatient liver care and diagnostics such as FibroScan with access to affiliated clinical research through Houston Research Institute. The organization appears to be physician-led by hepatologist Mazen Noureddin, MD, MHSc, and markets itself as bringing together compassionate patient care and cutting-edge liver research. Based on available evidence, it is best characterized as a commercial-stage specialty medical practice and research-focused healthcare provider rather than a therapeutics biotech or pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Houston Liver Institute.